Skip to main content

NeuroPace Inc

NPCE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001528287

No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding NeuroPace Inc changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of NPCE: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders5451−3
Shares13.4M14.4M+1.06M (+8.0%)
Value$176.4M$109.1M−$67.3M (−38.2%)

New holders (18)

Institutions that held NeuroPace Inc at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to NPCE in Q2 2024
InstitutionSharesValue% of portfolio
Deutsche Bank AG653,685$4.94M0.00%
Charles Schwab Investment Management Inc36,537$276.2K0.00%
Bank of New York Mellon Corp34,059$257.5K0.00%
Two Sigma Investments, LP33,094$250.2K0.00%
Bank of Montreal32,223$245.9K0.00%
Nuveen Asset Management, LLC18,420$139.3K0.00%
Rhumbline Advisers14,664$110.9K0.00%
New York State Common Retirement Fund14,300$108.1K0.00%
Alpine Global Management, LLC12,923$97.7K0.02%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.9,108$68.9K0.00%
Corebridge Financial, Inc.7,343$55.6K0.00%
Legal & General Group Plc1,508$11.4K0.00%
Ameritas Investment Partners, Inc.1,337$10.1K0.00%
Royal Bank of Canada1,283$10.0K0.00%
Jones Financial Companies LLLP1,000$7.56K0.00%
California State Teachers Retirement System989$7.48K0.00%
Amalgamated Bank472$4.00K0.00%
Simplex Trading, LLC370$2.00K0.00%

Sold out (21)

Institutions that held NeuroPace Inc at the end of Q1 2024 and filed for Q2 2024 without it.